Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT
CISA Cybersecurity Advisories·9h·Official
View CSAF Summary Successful exploitation of these vulnerabilities could allow an attacker to obtain sensitive health-related information and prevent legitimate users from establishing a connection with the device. The following versions of Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT are affected: Blood Glucose Monitoring System (Model No. APG-01 BT) 0x0110_v1.1.0 (CVE-2026-50034, CVE-2026-52866) CVSS Vendor Equipment Vulnerabilities v3 6.5 Apollo Pharmacy Apollo Pharmacy Blood Glu
Categories cybersecurity · government-security · privacy · vulnerability
Original source / advisory ↗Published
6/18/2026, 12:00:00 PM
Fetched
6/18/2026, 6:19:04 PM
Trust
official · 100/100
Language
en